Medical Devices; Quality Management System Regulation Technical Amendments
Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Dec. 4, 2025. Document 2025-21955. Updated Nov. 17, 2026.
- What it does
The Food and Drug Administration (FDA, the Agency, or we) is amending certain medical device regulations to revise references and language in existing Code of Federal Regulations (CFR) provisions to conform with the final rule "Medical Devices; Quality System Regulation Amendments" (QMSR Final Rule). This rule does not impose any new requirements on affected parties. This action is editorial in nature to correct errors, conform regulatory references, and ensure accuracy and clarity in the Agency's regulations.
The Food and Drug Administration's summary, as published in the Federal Register.
- What changed in the regulation
18 parts of Title 21 of the Code of Federal Regulations:
21 CFR 801, 21 CFR 803, 21 CFR 812, 21 CFR 860, 21 CFR 862, 21 CFR 864, 21 CFR 866, 21 CFR 868, 21 CFR 872, 21 CFR 874, 21 CFR 876, 21 CFR 878, 21 CFR 880, 21 CFR 882, 21 CFR 886, 21 CFR 888, 21 CFR 890, 21 CFR 892
Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).
- Compared with
The Food and Drug Administration has published 103 final rules in 2026 so far, compared with 68 in all of 2025.
Counted by the Tribune from Federal Register records since Jan. 1, 2025.
- What happens next and when
This rule is effective February 2, 2026.
The agency's dates, word for word.
The record as published
| Document number | 2025-21955 |
|---|---|
| Action | Final rule; technical amendments. |
| Agencies | Health and Human Services Department; Food and Drug Administration |
| Published | Dec. 4, 2025 |
| Effective date | Feb. 2, 2026 |
| Docket | FDA-2025-N-4635 |
Source: the Federal Register (public domain). The document in the Federal Register